Literature DB >> 10416836

Novel metabolites of the mammalian lignans enterolactone and enterodiol in human urine.

E Jacobs1, S E Kulling, M Metzler.   

Abstract

Enterolactone (ENL) and enterodiol (END) are found in high concentrations in human body fluids after ingestion of flaxseed and whole-grain products. Although much interest is presently focused on these mammalian lignans because of their putative beneficial health effects, little is known about their metabolic fate in humans. We have now identified nine novel metabolites of ENL and END in the urine of female and male humans ingesting flaxseed for five days. The chemical structures of six ENL metabolites and of three END metabolites were elucidated by GC/MS analysis and comparison with authentic reference compounds obtained by chemical synthesis. The six identified metabolites of ENL were the products of monohydroxylation at the para-position and at both ortho-positions of the parent hydroxy group of either aromatic ring. Likewise, the three END metabolites were formed through aromatic monohydroxylation at the para- and ortho-positions. The biological significance of these metabolites remains to be established.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10416836     DOI: 10.1016/s0960-0760(99)00033-3

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  3 in total

Review 1.  Interindividual differences in phytochemical metabolism and disposition.

Authors:  Johanna W Lampe; Jyh-Lurn Chang
Journal:  Semin Cancer Biol       Date:  2007-05-13       Impact factor: 15.707

Review 2.  Interindividual differences in response to plant-based diets: implications for cancer risk.

Authors:  Johanna W Lampe
Journal:  Am J Clin Nutr       Date:  2009-03-18       Impact factor: 7.045

Review 3.  Flaxseed Lignans as Important Dietary Polyphenols for Cancer Prevention and Treatment: Chemistry, Pharmacokinetics, and Molecular Targets.

Authors:  S Franklyn De Silva; Jane Alcorn
Journal:  Pharmaceuticals (Basel)       Date:  2019-05-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.